Skip to main content

Table 3 Multivariate logistic models for severe COVID-19 outcomes

From: Comparative epidemiology of five waves of COVID-19 in Mexico, March 2020–August 2022

Variable

COVID-19 outcome

Hospitalization

OR (95% CI)

Intubation

OR (95% CI)

In-hospital death

OR (95% CI)

Male sex

1.56 (1.54–1.57)

1.20 (1.18–1.22)

1.32 (1.30–1.34)

Age group

 20–

Ref.

Ref.

Ref.

 20–39

0.55 (0.540.57)

1.41 (1.301.54)

2.27 (2.072.48)

 40–59

1.86 (1.821.90)

2.18 (2.012.36)

5.12 (4.695.59)

 60+

12.56 (12.2612.86)

2.57 (2.372.79)

13.80 (12.6415.06)

Epidemic wave

 1st wave

Ref.

Ref.

Ref.

 2nd wave

0.54 (0.530.54)

0.74 (0.720.75)

1.43 (1.401.45)

 3rd wave

0.25 (0.250.26)

0.76 (0.740.78)

1.27 (1.241.30)

 4th wave

0.09 (0.090.09)

0.37 (0.360.39)

0.94 (0.910.97)

 5th wave

0.04 (0.040.04)

0.18 (0.160.19)

0.40 (0.380.42)

Previous medical conditions

 None

Ref.

Ref.

Ref.

 One

2.15 (2.122.17)

1.16 (1.131.18)

1.29 (1.271.32)

 Two or more

3.79 (3.743.83)

1.15 (1.131.18)

1.52 (1.491.55)

COVID-19 vaccination

 Unvaccinated/incomplete

Ref.

Ref.

Ref.

 Complete/booster

0.41 (0.40–0.41)

0.96 (0.92–0.99)

0.75 (0.73–0.78)

Intubation

14.37 (14.02–14.73)

ICU care

0.48 (0.46–0.51)

  1. The results of a multivariate logistic regression model are presented. The hospitalization model included 3,396,375 confirmed cases. The intubation and in-hospital death models comprise 373,646 hospitalized patients. Adjusted Odds ratio (OR) with 95% confidence intervals (95% CI) are shown
  2. Previous medical conditions included obesity, hypertension, diabetes, CPOD and cardiovascular disease
  3. For vaccination status, patients were classified into four groups: (1) unvaccinated, (2) with incomplete schema (with a single dose of vaccine AstraZeneca, Sputnik, Moderna, Novavax, Pfizer BioNTech, Sinopharma or Sinovac), (3) with complete schema (with two doses of the previous vaccines or one dose of CanSino or Janssen vaccines) and (4) with booster schema if the subject has a complete schema and an additional dose of any COVID-19 vaccine
  4. Epidemic waves correspond to the following onset of symptoms periods: the first wave from week 2020-14 to week 2020-40 (from March 29th, 2020 to October 3rd, 2020); the second wave from week 2020-41 until week 2021-21 (from October 4th, 2020 to May 29th, 2021); the third wave from week 2021-22 to week 2021-50 (from May 30th, 2021 until December 18th, 2021); the fourth wave from week 2021-51 to 2022-17 (from December 19th, 2021 to April 30th, 2022); and fifth wave from week 2022-18 to week 2022-34 (from May 1st, 2022 until August 27th, 2022)
  5. Statistically significant results are shown in bold text